Stay updated on Tisotumab Vedotin Safety in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision: v3.4.3 is shown on the page, replacing the previous v3.4.2. No other visible changes to the study details or layout are apparent.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.4.2 was added. The notice about government funding lapse and Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check62 days agoChange DetectedAdded a government funding notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedAdded a glossary display and updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and revision 3.4.0, while removing the older Last Update Submitted that met QC Criteria, No FEAR Act data, and revision 3.3.4.SummaryDifference0.2%

- Check76 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing Revision: v3.3.3; this is a small metadata update with no impact on the study content.SummaryDifference0.0%

Stay in the know with updates to Tisotumab Vedotin Safety in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page.